You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

2-chloro-3'-deoxyadenosine

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Aldosteronism Trial in Calgary ([18-F]CETO)

Not yet recruiting
  • Primary Aldosteronism
  • [18-F]CETO
  • Calgary, Alberta, Canada
    University of Calgary
Jul 22, 2022

Ann Arbor Stage II DLBCL, Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma Trial in Scottsdale,

Recruiting
  • Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
  • +13 more
  • Scottsdale, Arizona
  • +2 more
Jun 1, 2022

Primary Aldosteronism Due to Aldosterone Producing Adenoma, Primary Aldosteronism Due to Nodular Hyperplasia, Adrenal Cushing

Completed
  • Primary Aldosteronism Due to Aldosterone Producing Adenoma
  • +4 more
  • Uppsala, Sweden
    Uppsala University Hospital
Apr 29, 2022

Secondary Acute Myeloid Leukemia Trial in Houston (Cladribine, Cytarabine, Uproleselan)

Recruiting
  • Secondary Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Jun 25, 2021

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting
  • Fallopian Tube Carcinosarcoma
  • +28 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
Sep 2, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Lymph Nodes, Metastatic Prostate Carcinoma Trial in

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Los Angeles, California
  • +22 more
Feb 2, 2023

Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous

Suspended
  • Advanced Head and Neck Squamous Cell Carcinoma
  • +17 more
  • Gilbert, Arizona
  • +19 more
Dec 31, 2022

Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma

Recruiting
  • Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
  • +18 more
  • Duarte, California
    City of Hope Medical Center
Feb 16, 2022

Hairy Cell Leukemia Trial run by the NCI (Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin)

Active, not recruiting
Has Results
  • Hairy Cell Leukemia
  • Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 13, 2022

Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (drug, biological, other)

Completed
Has Results
  • Acute Leukemia of Ambiguous Lineage
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 23, 2022

Locally Advanced Pancreatic Adenocarcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer

Recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • +6 more
  • Hypofractionated Radiation Therapy
  • +2 more
  • Duarte, California
  • +29 more
Apr 2, 2022

Acute Myeloid Leukemia Trial in Seattle (drug, biological, other)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 10, 2022

Untreated Adult Acute Myeloid Leukemia Trial in Houston (Cladribine, Guadecitabine, Idarubicin)

Completed
Has Results
  • Untreated Adult Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Apr 28, 2022

Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia Trial in Houston (drug, other, biological)

Recruiting
  • Hairy Cell Leukemia
  • Recurrent Hairy Cell Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Mar 20, 2020

Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia-2, High Grade Malignant Tumor Trial in

Completed
Has Results
  • Blasts 10 Percent or More of Bone Marrow Nucleated Cells
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 11, 2021

Healthy Trial in Houston (Placebo, AV-101 720 mg, AV-101 1440 mg)

Completed
Has Results
  • Healthy
  • Placebo
  • +2 more
  • Houston, Texas
    Michael E. DeBakey VA Medical Center
Feb 16, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Olfactory Cleft Stenosis and Obstruction on Paranasal Sinus CT

Recruiting
  • Olfactory Impairment
    • Nancy, France
    • +1 more
    Oct 8, 2023

    Type 1 Diabetes With Diabetic Nephropathy Trial in Worldwide (Sotagliflozin, Ambrisentan, Ambrisentan and Sotagliflozin)

    Not yet recruiting
    • Type 1 Diabetes Mellitus With Diabetic Nephropathy
    • Aurora, Colorado
    • +6 more
    Oct 2, 2023

    Post COVID-19 Condition (PCC) Trial in E. Amherst, Milan (RDX-19)

    Recruiting
    • Post COVID-19 Condition (PCC)
    • RDX-19
    • E. Amherst, New York
    • +1 more
    Oct 30, 2023

    Colon Cancer, Rectal Cancer, Liver Metastases Trial in San Francisco (Tas-102, SIR-Sphere)

    Completed
    • Colon Cancer
    • +2 more
    • San Francisco, California
      University of California San Francisco
    Jul 28, 2022

    Type 1 Diabetes, Type 2 Diabetes Trial in Neuss (sotagliflozin (SAR439954))

    Completed
    • Type 1 Diabetes Mellitus
    • Type 2 Diabetes Mellitus
    • sotagliflozin (SAR439954)
    • Neuss, Germany
      Investigational Site Number 276001
    Apr 5, 2022

    Carcinoma, Renal Cell Trial in France (Tivozanib, Nivolumab)

    Completed
    • Carcinoma, Renal Cell
    • Bordeaux, France
    • +3 more
    Dec 2, 2021

    Heart Failure With Preserved Ejection Fraction Trial in New York (Sotagliflozin, Placebo)

    Recruiting
    • Heart Failure With Preserved Ejection Fraction
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Nov 17, 2022

    Nephropathy, Diabetic Nephropathies, Diabetes, Type 1 Trial in Herlev (Sotagliflozin, Placebo)

    Not yet recruiting
    • Nephropathy
    • +6 more
    • Herlev, Denmark
      Steno Diabetes Center Copenhagen
    Nov 19, 2023